Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6427-6432

  Hong, Kenneth ^a   Greer, Catherine E ^a   Ketter, Nzeera ^a   Van Nest, Gary ^a   Paliard, Xavier ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; ARTICLE; CELL ISOLATION; CONDYLOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; WART VIRUS;

EID: 0030750388     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6427-6432.1997     Document Type: Article

References (38)

1. Altman, A., I. Jochmus-Kudielka, R. Frank, H. Gausepohl, U. Moebius, L. Gissmann, and S. C. Mener. 1992. Definition of immunogenic determinants of the human papillomavirus type 16 nuelcoprotein E7. Eur. J. Cancer 28:326-333.
2. Bartholomew, J. S., S. N. Stacey, B. Coles, D. J. Burt, J. R. Arrand, and P. L. Stern. 1994. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Eur. J. Immunol. 24:3175-3179.
3. Bauer, H. M., C. E. Greer, and M. M. Manon. 1992. Detection of genital human papillomavirus using PCR. p. 131-152. In C. S. Herrington and J. O. McGee (ed.), Diagnostic molecular pathology:a practical approach. Oxford University Press. Oxford, England.
4. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manus. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
5. Bishop, P. E., A. McMillan, and S. Flesher. 1990. An immunohistological study of spontaneous regression in condylomata acuminata. Genitourin. Med. 66:79-81.
6. Brenner, M. B., J. L. Strominger, and M. S. Krangel. 1988. The γδ T cell receptor. Adv. Immunol. 43:133-192.
7. Carter, J. J., G. C. Wipf, M. E. Hagensee, B. McNight, L. A. Habel, S. Lee, J. Kuypers, N. Kiviat, J. R. Daline, L. A. Koutsky, D. H. Watts, K. K. Holmes, and D. Galloway. 1995. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J. Infect. Dis. 172:11-18.
8. Charleston, F. C., N. Norval, E. C. Bentun, and J. A. A. Hunter. 1992. Lymphoproliferative responses to human papillomaviruses in patients with cutaneous warts. Br. J. Dermatol. 127:551-559.
9. Colemun, N., H. D. L. Birley, A. M. Renton, N. F. Hanna, B. K. Ryait, M. Byrne, D. Taylor-Robinson, and M. A. Stanley. 1994. Immunological events in regressing warts. Am. J. Clin. Pathol. 102:768-774.
10. Gassenmaier, A. F., G. Fuchs, H. Schell, and H. Pfister. 1986. Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch. Dermalol. Res. 278:219-223.
11. 10a.Greer, C. E., et al. Unpublished data.
12. l0b.Greer, C. E., and X. Paliard. Unpublished data.
13. Greer, C. E., C. M. Wheeler, M. B. Ladner, K. Butner, M. Y. Coyle, H. Liang, A. Langenberg, T. S. B. Yen, and R. Ralston. 1995. Human papillomavirus type distribution and serological response to HPV type 6 virus-like particles in subjects with genital warts. J. Clin. Microbiol. 33:2058-2063.
14. Groh, V., S. Porcelli, M. Fabbi, L. L. Lanier, L. J. Picker, T. Anderson, R. A. Warnke, A. K. Bhan, J. L. Strominger, and M. B. Brenner. 1989. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med. 169:1277-1294.
15. Hannet, I., F. Erkeller-Yuksel, P. Lydyard, V. Deneys. and M. DeBruyere. 1992. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol. Today 13:215-218.
16. Heim, K., N. D. Christensen, R. Hoepfl, B. Wartush, G. Pinzger, P. Baumgartner, J. W. Kreiden and O. Dapunt. 1995. Serum IgG, IgM and IgA reactivity to humun papillomavirus types 11 and 6 virus-like particles in different gynecological subjects groups. J. Infect. Dis. 172:395-402.
17. Höpfl, R., M. Sandbichler, N. Sepp, K. Heim, E. Muller-Holzne, B. Wartusch, O. Dapunt, I. Jochmus-Kudielka, J. ter Meulen, L. Gissmann, and P. Fritsch. 1991. Skin test for HPV type 16 proteins in cervical intraepithelial neoplasia. Lancet 337:373-374.
18. Iwatsuki, K., H. Tayami, M. Takigawa, and M. Yamada. 1986. Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch. Dermatol. 122:655-659.
19. Johnson, J. C., A. F. Burnett, G. D. Willet, M. A. Young, and J. Doniger. 1992. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency-virus-infected women. Obstet. Gynaecol. 79:321-327.
20. Kadish, A. S., S. L. Romney, R. Ledwidge, R. Tindle, G. J. P. Fernando, S. Y. Zee, M. A. Van Ranst, and R. D. Burk. 1994. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) lype 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J. Gen. Virol. 75:2277-2284.
21. Kaufmann, S. H. E. 1990. γ/δ and other unconventional T lymphocytes:what do they see and what do they do? Proc. Natl. Acad. Sci. USA 93:2272-2279.
22. Luxton, J. C., A. J. Rowe, J. C. Cridland, T. Coletart, P. Wilson, and P. S. Shepherd. 1996. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical displasia and cervical carcinoma and in healthy individuals. J. Gen. Virol. 77:1585-1593.
23. Melbye, M., J. Palefsky, J. Gonzales, L. P. Ryder, H. Neilsen, O. Bergmann, J. Pindborg, and R. J. Biggar. 1990. Immune status as a determinant of humun papillomavirus detection and its association with anal epithelial abnormalities. Int. J. Cancer 46:203-206.
24. Modlin, R. L., C. Pirmez, F. M. Hofman, V. Torigian, K. Uyemura, T. H. Rea, B. R. Bloom, and M. B. Brenner. 1989. Lymphocytes hearing antigen-specific γδ T cell receptors accumulate in human infectious disease lesions. Nature 339:544-548.
25. Orth, G. 1987. Epidermodysplasia verruciformis, p. 199-235. In N. P. Salzman and P. M. Howley (ed.), The Papovaviridae. Planum Press, New York N.Y.
26. Purreco, R., I. Penn, W. Droegemueller, B. Greer, and E. Makowski. 1975. Gynaecological malignancies in immunosuppressed organ homograft recipients. Obslet. Gynaecol. 45:359-364.
27. Sadovnikova, E., and H. J. Stauss. 1994. T cell epitopes in human papilloma virus proteins. Behring Inst. Mitt. 94:87-93.
28. Sciammas, R., R. M. Johnson, A. I. Sperling, W. Brady, P. S. Linsley, P. G. Spear, F. W. Fitch, and J. A, Bluestone. 1994. Unique antigen recognition by a herpesvirus-specific TCRγδ cell. J. Immunol. 152:5392-5397.
29. Shah, K. V., and P. M. Howley. 1990. Papillomaviruses, p. 2077-2109. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
30. Shepherd, P. S., A. J. Rowe, J. C. Cridland, T. Coletart, P. Wilson, and J. C. Luxton. 1996. Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. J. Gen. Virol. 77:593-602.
31. Steele, J. C., T. Stankovic, and P. H. Gallimore. 1993. Production and characterization of human proliferative T-cell clones specific for human papillomavirus type l E4 protein. J. Virol. 76:2799-2806.
32. Stoler, M. H., S. M. Wolinsky, A. Whitbeck, T. R. Broker, and L. T. Chow. 1989. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340.
33. Stone, K. M. 1995. Human papillomavirus infection and genital warts:update on epidemiology and treatment. Clin. Infect. Dis. 20(Suppl. 1):S91-S97.
34. Strang, G., J. K. Hickling, G. A. J. McIndoe, K. Rowland, D. Wilkinson, H. Ikeda, and J. B. Rothbard. 1990. Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides:identification of T cell determinants, HLA-DR restriction and virus type specificity. J. Gen. Virol. 71:423-431.
35. Tagami, R. W., M. Oguchi, and S. Ofuji. 1993. Immunological aspects of wart regression with special reference to regression phenomenon of numerous flat warts. An experiment on tumor immunity in man by nature. J. Dermatol. 10:1-12.
36. Tarpey, I., S. Stacey, J. Hickling, H. D. Birley, A. Renton, A. McIndoe, and D. H. Davies. 1994. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology 81:222-227.
37. Wilkström, A., G. J. J. van Doornum, R. Kirnbauer, W. G. V. Quint, and J. Diller. 1995. Prospective study on the development of antibodies against human papillomavirus type 6 among subjects with condyloma acuminata or new asymptomatic infection. J. Med. Virol. 46:368-374.
38. Wilkström, A., G. J. J. van Doornum, W. G. V. Quint, J. T. Schiller, and J. Diller. 1995. Identification of human papillomavirus seroconversions. J. Gen. Virol. 76:529-539.